- Ticker
- ACARIX.ST
- Price
- 0.25
- Stock movement up
- +0.00 (1.82%)
- Company name
- Acarix A/S
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 104.21M
- Ent value
- -
- Price/Sales
- 17.90
- Price/Book
- 2.01
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -15.49%
- 1 year return
- -52.60%
- 3 year return
- -42.62%
- 5 year return
- -28.26%
- 10 year return
- -
Last updated: 2024-04-09
DIVIDENDS
ACARIX.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 17.90 |
| Price to Book | 2.01 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 413.54M |
| EPS (TTM) | -0.28 |
| FCF per share (TTM) | -0.47 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 5.82M |
| Gross profit (TTM) | 4.62M |
| Operating income (TTM) | -76.47M |
| Net income (TTM) | -76.98M |
| EPS (TTM) | -0.28 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 79.35% |
| Operating margin (TTM) | -1313.55% |
| Profit margin (TTM) | -1322.29% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 892.00K |
| Total current assets | 53.67M |
| Goodwill | 0.00 |
| Intangible assets | 14.86M |
| Property, plant and equipment | 0.00 |
| Total assets | 69.48M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 17.66M |
| Total liabilities | 17.66M |
| Shareholder's equity | 51.83M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -131.49M |
| Capital expenditures (TTM) | 293.00K |
| Free cash flow (TTM) | -131.78M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -148.54% |
| Return on Assets | -110.80% |
| Return on Invested Capital | -148.54% |
| Cash Return on Invested Capital | -254.28% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.26 |
| Daily high | 0.26 |
| Daily low | 0.24 |
| Daily Volume | 2.57M |
| All-time high | 8.29 |
| 1y analyst estimate | 0.63 |
| Beta | 1.53 |
| EPS (TTM) | -0.28 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 14 May 2024 |
Downside potential
Loading...
Downside potential data
| ACARIX.ST | S&P500 | |
| Current price drop from All-time high | -96.96% | -0.85% |
| Highest price drop | -97.86% | -56.47% |
| Date of highest drop | 21 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -77.27% | -11.35% |
| Avg time to new high | 368 days | 13 days |
| Max time to new high | 1837 days | 1805 days |
COMPANY DETAILS
Marketcap
104.21M
Marketcap category
Small-cap
Description
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyse the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to collect real-world data to compare workflows between traditional stres...
April 11, 2024
Acarix, a leader in acoustic-based Cardiac Diagnostics, is pleased to announce the results from a 2024 American College of Cardiology (ACC) poster presentation by Suzanne Baron, MD, MSc, Director of I...
April 8, 2024
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of three new advisors to its team. Joining the advisory board are Ken Nelson, known for his leadership in the...
February 15, 2024
Acarix, a leader in advanced acoustic-based cardiac diagnostic devices today announces the CADScor® System has been added to the United States Federal Supply Schedule (FSS). The nationwide contract si...
February 5, 2024